Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Post Market Clinical Registry for the Zenflow Spring System - A Minimally Invasive Treatment for LUTS Associated With BPH Spring System Registry

NCT07538622 is registered in ClinicalTrials.gov with Zenflow, Inc. as lead sponsor.

NCT NCT07538622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07538622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Post Market Clinical Registry for the Zenflow Spring System - A Minimally Invasive Treatment for LUTS Associated With BPH Spring System Registry
Lead sponsor
Zenflow, Inc.
Phase
Observational
Overall status
Recruiting
Start date
July 29, 2026
Completion date
September 30, 2028
Enrollment
300 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

bph (benign prostatic hyperplasia)